Focus on clinical research:
- Diagnostics, prognosis and therapy optimization in AML
- Diagnostics, prognosis and therapy optimization in CML
- Prognostic factors and therapy optimization in MDS
- Diagnostics, prognosis and therapy optimization in mastocytosis
- Therapy optimization in clinical haematology at an advanced age
- Establishment of personalized medicine for myeloid neoplasms
Focus on basic research:
- Basophilic granulocytes and tissue mast cells
- Pathophysiology of AML, CML, MDS and mastocytoses
- Eosinophilic granulocytes and eosinophilic leukemias
- Oncogene-dependent signal transduction in leukemia cells
- Identification of new therapeutic targets in neoplastic cells
- Characterization and eradication of leukemic stem cells
- Synergistic effect of new antileukemic drugs
Coordination of networks:
- European Competence Network for Mastocytosis (ECNM)
- International Cooperative Working Group on Eosinophilic Diseases (ICOG-EO)
- Special Research Area (SFB) Myeloproliferative Neoplasia (SFB-F47)
- Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO)
- Clinical Center of Excellence of the MDS Foundation
- Center of Excellence and Reference Center of the ECNM
Honors/awards:
1989: Paracelsus Prize of the Austrian Society for Internal Medicine
1989: Karl Landsteiner Prize of the Austr. Soc. f. Allergol. and Immunology
1990: Prize of the Hoechst company
1991: Wilhelm-Türk-Prize of the Austr. Soc. f. Hematology and Oncology
1991: Theodor Billroth Prize of the Vienna Medical Association
1992: Prize of the Hoechst company
1992: Denk Prize of the Austr. Soc. f. Hematology and Oncology
1992: Austrian Sandoz Prize
1994: Denk Prize of the Austr. Soc. f. Hematology and Oncology
1995: Theodor Billroth Prize of the Vienna Medical Association
1995: Mack-Forster Prize of the European Soc. for Clinical Investigation
2006: Central European Prize for Interdisciplinary Cancer Research